• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • UDI Database of NMPA: Understand It Within 6 Minutes

UDI Database of NMPA: Understand It Within 6 Minutes

Monday, 28 September 2020 / Published in Medical Device, News, NMPA Registration in China

UDI Database of NMPA: Understand It Within 6 Minutes

The NMPA (National Medical Products Administration) released a short introductory video about the online UDI database, soon to be implemented for the first batch of medical devices on October 1, 2020.

Video Highlights

  • The Unique Device Identifier (UDI) is the ID number of medical device
    • Enabling the traceability of all medical devices
    • Strengthening the product management during the enter life cycle
    • Improve the efficiency of market supervision
  • The UDI is a set of unique codes combined by the Device Identifier (DI) and Production Identifier (PI)
    • The DI records static information related to the product
    • The PI records dynamic information related to the production process
  • The UDI system consists of the UDI, UID carrier and UDI database
  • In October 2019, the NMPA issued the UDI requirements of the first batch of medical devices
  • The UDI database officially launched in March 2020 following the pilot phase in December 2019

As of September 7, 2020, a total of 98,919 medical devices and IVDs had successfully registered for the UDI code.

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: UDI, Unique Device Identification

What you can read next

Draft of TSG 22 for mobile pressure vessels published for comments
Regulation on safety supervision of special equipment
Regulation on safety supervision of special equipment – Draft amendment issued
China drug annual reports
China Drug Annual Reports – How to File in China?

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP